We’ve gone VIRTUAL!
Due to the pandemic, for the safety and comfort of our speakers and delegates, ECN2021 will now take place online via a dedicated virtual platform.
The conference will be broadcast at CEST (Central European Summer Time)/ -2 GMT / -1 BST (British Summer Time).
It is our pleasure to inivte you to partcipate in The Virtual 2nd European Conference on Neuroinflammation – Basic and Clinical Concepts (ECN2021) in association with The Oxford Centre for Neuroinflammation taking place 12-13 April 2021 online.
The ECN2021 conference follows on from the hugely successful inaugural ECN2019, which took place in London, UK in April 2019. We have received a wealth of positive feedback from the speakers and the attendees at ECN2019 and we will again strive to facilitate investigative and analytical discussion of a range of neurodegenerative diseases. The focus will be on multiple sclerosis as a paradigmatic neuroinflammatory and neurodegenerative disease but we will also have talks on neuromyelitis optica and Alzheimer’s disease to allow for cross-fertilizing discussions.
Through a comprehensive scientific programme with a broad basic and therapeutic focus, our world-renowned faculty will address the entire spectrum from basic aspects of neuroinflammation and neurodegeneration to state-of-the-art and emerging treatments of multiple sclerosis, neuromyelitis optica and Alzheimer’s disease.
Key topics addressed will include:
- Genetic and immunological understandings of multiple sclerosis, neuromyelitis optica and Alzheimer’s disease
- Clinical management of neuroinflammation and neurodegeneration, with particular focus on multiple sclerosis
- Emerging concepts for understanding and treating patients, with a particular focus on multiple sclerosis
The conference is held in association with the Oxford Centre for Neuroinflammation (OCNI), which aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.
We hope you will join us for a fruitful and insightful conference.
Conference Chairs: Joan M Goverman, USA, Kate Attfield, UK, and Lars Fugger, UK